As of January 23, 2025, PaxMedica (PXMD) has a market cap of $337,255 Dollars USD. According to our data, PaxMedica is ranked No.9285 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $337,255 Dollars |
-50.00%
|
Dec 31, 2024 | $0.67 M |
-91.81%
|
Dec 29, 2023 | $8.24 M |
-97.81%
|
Dec 30, 2022 | $0.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Corbus Pharmaceuticals
CRBP
|
$0.14 B |
-0.000 M
|
USA
|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Marinus Pharmaceuticals
MRNS
|
$30.09 M |
0.000 M
|
USA
|
BioXcel Therapeutics
BTAI
|
$18.04 M |
0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
ACADIA Pharmaceuticals
ACAD
|
$2.96 B |
-0.000 M
|
USA
|
Minerva Neurosciences
NERV
|
$14.76 M |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
Market Cap | = | PXMD Stock Price | * | PXMD Shares Outstanding |
= | $0.03 | * | 10.88 M | |
= | $337,255 Dollars |